The internationally prestigious Labiofam Entrepreneurial Group is currently engaged in the development of important projects for human health around the globe, especially in areas where onchocerciasis, leptospirosis and black fly influenza, among others, reach high levels of endemism.

Labiofam S.A. is the entity commercializing products and services from the organizations integrating the Group in both domestic and foreign markets. It also offers environmental health services.

Presently, Labiofam S.A. has commercial relations with national and foreign companies, and sales in over 35 countries. Some examples are offered below:

LATIN AMERICA
Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guatemala, Haiti, Honduras, México, Nicaragua, Paraguay, Peru, Dominican Republic, Venezuela

ASIA
China, Sri Lanka and Vietnam

AFRICA
Angola, Algeria, Benin, Burkina Faso, Congo, Egypt, Gambia, Gabon, Ghana, Guinea Bissau, Guinea Conakry, Equatorial Guinea, Mozambique, Nigeria, Senegal , Sierra Leona, South Africa, Tanzania, Uganda, Zambia, Zimbabwe

EUROPE
Spain, United Kingdom, Rumania, Italia, France and Serbia

LABIOFAM has made significant contributions to reducing the morbility and mortality caused by these diseases, which are typical of remote, hard to reach locations.

The table below contains representative data of Labiofam’s activity abroad: